Phase II study of durvalumab following neoadjuvant chemoRT in operable rectal cancer: NSABP FR-2

George, TJ; Yothers, G; Jacobs, SA; Finley, GG; Wade, JL; Lima, CMSPR; Rose, JS; Pahuja, S; Krishnamurthy, A; Krauss, JC; Deutsch, M; Fabregas, JC; Lee, JJ; Allegra, CJ; Wolmark, N

JOURNAL OF CLINICAL ONCOLOGY, 2022; 40 (4):

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索